Hyderabad, April 11: The International Society for Diseases of the Esophagus (ISDE), in association with Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH & RI), is hosting the prestigious ISDE India Edition 2026 at The Westin Hyderabad Mindspace on April 10 and 11, 2026. Marking a significant milestone, this is the first time the global conference is being held in India.
The conference will be inaugurated by Nandamuri Balakrishna, Chairman & Managing Trustee, NBTRMCF, and will bring together over 150 leading oncologists and specialists from across the world. Experts from countries including Canada, Singapore, Japan, Australia, and the United States will join prominent Indian clinicians and researchers to exchange insights and advancements in esophageal cancer care.
The event also coincides with the Silver Jubilee celebrations of Basavatarakam Indo-American Cancer Hospital & Research Institute, underscoring its legacy as one of India’s premier cancer care institutions.
Esophageal cancer remains one of the most aggressive and underdiagnosed malignancies globally, with India contributing significantly to the disease burden. The conference will address key risk factors, including tobacco and alcohol use, GERD, obesity, dietary habits, and region-specific contributors such as consumption of very hot beverages and malnutrition. Experts will also discuss challenges in early detection and the rising incidence in regions such as the North-East and Kashmir.
Speaking on the occasion, Lorenzo Ferri, President of ISDE and Director of the Upper GI Cancer Program at McGill University, said:
“Esophageal cancer is a highly aggressive disease where precision is critical. India has demonstrated remarkable expertise in managing this condition. By integrating global insights and sharing best practices, we can advance toward more standardized and effective treatment approaches worldwide.”
Dr. T. Subramanyeswara Rao, Medical Director & Chief Surgical Oncologist at BIACH & RI and President of IASO, highlighted the significance of the conference:
“This event represents a defining moment in strengthening India’s position in the global fight against esophageal cancer. Advances in technology and specialized care have significantly improved outcomes, and continued collaboration will further enhance treatment effectiveness.”
Dr. C. S. Pramesh, Director of Tata Memorial Hospital, emphasized the importance of accessible and region-specific cancer care:
“A large proportion of patients travel long distances for treatment, and many discontinue due to associated costs. Strengthening a nationwide network of cancer centres and leveraging digital tools can significantly improve access, consistency, and research outcomes.”
The conference will showcase cutting-edge advancements in esophageal cancer treatment, including minimally invasive and robotic esophagectomy, Endoscopic Submucosal Dissection (ESD) for early-stage cancers, advanced multimodal therapies, and translational research enabling precision medicine.
A distinguished international faculty, including experts from leading global institutions, will participate in the event, fostering collaboration and knowledge exchange to improve clinical outcomes worldwide.
As India continues to emerge as a hub for high-quality and cost-effective healthcare, initiatives like ISDE India Edition 2026 are expected to boost medical innovation, strengthen global partnerships, and enhance patient care standards.
